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Cancer cachexia, characterized by weight loss, muscle atrophy, and loss of
appetite, accounts for almost a third of cancer-related deaths. Zhou et al.
now identify the activin receptor ActRIIB as a key player in cachexia-related
muscle wasting. Inhibition of ActRIIB in cancer cachexia models reverses
muscle loss by attenuating protein degradation and stimulating myogenesis.
This inhibition also reverses cancer-induced heart atrophy and prolongs the
life spans of tumor-bearing mice without affecting tumor growth or fat loss.
These results suggest that ActRIIB antagonism holds therapeutic potential for
combating cancer cachexia and muscle wasting diseases.Helicase Clears the Track for Replication
PAGE 544Although first described as DNA-unwinding enzymes, helicases are now appreciated to serve various functions within cells.
In this issue, Park et al. show that during replication the PcrA helicase anchors itself to the duplex DNA while translocating on
the lagging strand, effectively reeling it in. This activity helps strip RecA filaments off the DNA, suggesting a mechanism for
preventing uncontrolled recombination.A Half-Full and Half-Empty EGFR
PAGE 568
Epidermal growth factor (EGF) binding induces dimerization and activation of its receptor, EGFR. Both ‘‘high-affinity’’ and
‘‘low-affinity’’ receptors are detected on cell surfaces. Studying the Drosophila EGF receptor, Alvarado et al. show how these
two affinity classes arise through negative cooperativity. Crystal structures reveal that EGFR dimers can contain ligand in only
one of the two ligand-binding sites. The authors provide evidence that ligand binding in this one high-affinity site induces
a conformation change in the other binding site that renders it low affinity. The results may help explain different signaling
properties for different classes of EGFR ligands and inhibitors.Monopolin Braces Chromosomes for Meiosis
PAGE 556
In the first meiotic division, duplicated sister chromatids orient towards the
same pole of the spindle, in contrast to their bipolar orientation in normal cell
divisions. In the yeast S. cerevisiae, the monopolin complex regulates this
meiotic movement of chromosomes. Corbett et al. show that the conserved
core of the monopolin complex forms a V shape that binds and crosslinks
kinetochore proteins, indicating that sister chromatid co-orientation occurs
through direct crosslinking of sister kinetochores. The results suggest that
a similar mechanism may contribute to successful meiosis in eukaryotes
more broadly.MO’ AGgregation in Neurodegeneration
PAGE 601Aggregation of disease proteins is amajor hallmark of neurodegenerative disorders. How these aggregates are formed during
cellular aging is poorly understood. Here van Ham et al. identify a regulator of this process, MOAG-4/SERF, which promotes
the formation of aggregates. Inactivation of MOAG-4/SERF suppresses aggregation and protects cells from the toxicity of
aggregation-prone disease proteins. These results open up new avenues for potential therapeutic approaches to treating
age-related, neurodegenerative diseases.Cell 142, August 20, 2010 ª2010 Elsevier Inc. 497
The Bare Bones of Voltage Sensing
PAGE 580
Voltage-gated ion channels sense voltage changes via a paddle-shaped motif that
harbors four positively charged, voltage-sensing residues that are separated by
hydrophobic residues. Xu et al. identify the minimal core of the paddle motif sufficient
to confer voltage gating to the Shaker K+ channel. The authors show that, surprisingly,
a large portion of the paddle is dispensable for voltage gating. The minimal core
contains the key voltage-sensing residues where the interleaved hydrophobic resi-
dues help to set the equilibrium between the activated and deactivated states of
the channel.All in a Day’s Work for the Immunoproteasome
PAGE 613Interferon (IFN)-induced immunoproteasomes (i-proteasomes) are associated with improved breakdown of antigens for
presentation to T cells. Seifert et al. now show that i-proteasomes protect cell viability when a cell is exposed to inflammatory
cytokines during an immune response. IFNs trigger the production of reactive oxygen species that induce protein oxidation
and formation of protein aggregates. The i-proteasome allows for efficient clearance of these aggregates. Thus, rather than
a specific role in peptide antigen production, i-proteasomes increase the peptide supply as part of a general role in protein
homeostasis.ATG12 Puts a Hit on Mitochondria
PAGE 590
ATG12 is an ubiquitin-like modifier required for autophagy with a single known
conjugation target, the autophagy regulator ATG5. Now, Radoshevich et al.
demonstrate that ATG12 can also be conjugated to ATG3. As individual proteins,
both ATG12 and ATG3 are essential for early autophagosome formation. In
contrast, the ATG12-ATG3 conjugate has no observed effects on autophagy.
Rather, the ATG12-ATG3 conjugate formation regulates mitochondrial mass and
cell death mediated by mitochondrial pathways. These results implicate the
ATG12 conjugation system in functions distinct from autophagosome formation.Variety Is the Splice of Life
PAGE 625
Alternative pre-mRNA splicing is a major source of biological regulation and diver-
sity, but defining its roles in complex physiological processes, such as apoptosisand disease, remains challenging. Moore et al. use a high-throughput screening platform to uncover numerous proteins
that regulate splicing of human Bcl-x andMcl1mRNAs, which encode Bcl2 family apoptosis factors. The assembled network
is enriched for regulators of the cell cycle, and inhibition of theG2/M andmitotic spindle checkpoints favors coordinated proa-
poptotic splicing. Their findings reveal a functionally coherent splicing network linking cell-cycle arrest to apoptosis.Caspases Cut to the Core of Proteolysis
PAGE 637
Apoptosis is an essential signaling pathway in metazoans driven by proteases called caspases. Gray et al. develop and use
a small-molecule-inducible protease, SNIPer, to dissect the nonredundant roles of the three executioner caspases in orches-
trating apoptosis. Although all three caspases are transiently activated, only activation of caspase-3 or -7 is sufficient to
induce apoptosis. In addition, more than half of 26S proteasome subunits were found to be caspase targets during apoptosis.
These findings have implications for the combined clinical use of proteasome inhibitors and proapoptotic drugs in treating
cancer.Cell 142, August 20, 2010 ª2010 Elsevier Inc. 499
